Flecainide: a new agent for the treatment of ventricular arrhythmias.
Flecainide has been shown to be a relatively safe and effective antiarrhythmic agent. Its twice daily dosage schedule and demonstrated efficacy in suppression of ventricular ectopy suggest that it will be a valuable agent in the therapy of ventricular arrhythmias.
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004562:Electrocardiography; D005424:Flecainide; D006352:Heart Ventricles; D006801:Humans; D007700:Kinetics; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D010880:Piperidines; D005424:Flecainide